February 2016’s results reporting season was certainly a moment and perhaps no results report captured the spirit of the season better than Slater and Gordon’s interim results announcement on Monday 29 February 2016: statutory NLAT of $958.3 million due to an $876.4 million non-cash impairment charge of which $814.2 million... Show More

Contango Asset Management

In February the CTN investment portfolio returned 9.9%, Best performers included Mayne Pharma (MYX, which rose 52%) after they announced the acquisition of Doryx from its distribution partner Actavis. Other major contributors over the month included GBST (GBT, 32%), Altium (ALU, 34%), Sino Gas and Energy (SEH, 48%) and Slater... Show More

OC Funds Management

Slater & Gordon has created a powerful brand in the Australian personal injury market and its domestic roll-up strategy has generated strong financial returns in recent years. Its aggressive push into the UK legal market has now seen the company benefit from 'first mover' advantage in the UK personal injury... Show More